caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1811929508

Han DangM.D.

Internal MedicineHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Han Dang's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 26 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NPI 1255335535114883
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
79297
CHCA BAYSHORE LP50250
City Of Houston
Ambulance Service Provider · Houston, TX
3693
EAST HOUSTON KIDNEY CENTER LP29446
SJ MEDICAL CENTER, LLC2872
Christopher Bathurst
Diagnostic Radiology · College Station, TX
2289
YOM, SUN2285
Eric Peden
Vascular Surgery · Houston, TX
21107
Joey Buquing
Internal Medicine · Houston, TX
21148
Vivek Bansal
Diagnostic Radiology · Houston, TX
2089
Jennifer Everett - Damewood
Internal Medicine · Hendersonville, TN
1992
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
286
Unique beneficiaries
—
Total services
758
Distinct HCPCS
6
Medicare payment
$127K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 6,183 Internal Medicine providers in TX — above median (cohort median 673).
PRESCRIBING · PART D · 2024
Total Rx claims
2,715
Beneficiaries
—
Total drug cost
$964K
Distinct drugs
52
Brand share
37.3%
Top prescribed drugs
Allopurinol242 claims
Dapagliflozin Propanediol183 claims
Finerenone153 claims
Carvedilol143 claims
Nifedipine126 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
86.0
Cost
81.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
92
By payment type
Food and Beverage$2K
Travel and Lodging$13